Theresa R. Fletcher
Pfizer
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Theresa R. Fletcher.
Bioorganic & Medicinal Chemistry Letters | 2010
Stephen A. Kolodziej; Susan L. Hockerman; Terri L. Boehm; Jeffery N. Carroll; Gary A Decrescenzo; Joseph J. Mcdonald; Debbie A. Mischke; Grace E. Munie; Theresa R. Fletcher; Joseph G. Rico; Nathan W. Stehle; Craig Swearingen; Daniel P. Becker
A series of phenyl piperidine alpha-sulfone hydroxamate derivatives has been prepared utilizing a combination of solution-phase and resin-bound library technologies to afford compounds that are potent and highly selective for MMP-13, are dual-sparing of MMP-1 and MMP-14 (MT1-MMP) and exhibit oral bioavailability in rats.
Journal of Medicinal Chemistry | 2016
Peter G. Ruminski; Mark A. Massa; Joseph Walter Strohbach; Cathleen E. Hanau; Michelle A. Schmidt; Jeffrey A. Scholten; Theresa R. Fletcher; Bruce C. Hamper; Jeffery N. Carroll; Huey S. Shieh; Nicole Caspers; Brandon Collins; Margaret L. Grapperhaus; Katherine E. Palmquist; Joe T. Collins; John E. Baldus; Jeffrey Hitchcock; H. Peter Kleine; Michael David Rogers; Joseph J. Mcdonald; Grace E. Munie; Dean Messing; Silvia Portolan; Laurence O. Whiteley; Teresa Sunyer; Mark E. Schnute
Matrix metalloproteinase-13 (MMP-13) is a zinc-dependent protease responsible for the cleavage of type II collagen, the major structural protein of articular cartilage. Degradation of this cartilage matrix leads to the development of osteoarthritis. We previously have described highly potent and selective carboxylic acid containing MMP-13 inhibitors; however, nephrotoxicity in preclinical toxicology species precluded development. The accumulation of compound in the kidneys mediated by human organic anion transporter 3 (hOAT3) was hypothesized as a contributing factor for the finding. Herein we report our efforts to optimize the MMP-13 potency and pharmacokinetic properties of non-carboxylic acid leads resulting in the identification of compound 43a lacking the previously observed preclinical toxicology at comparable exposures.
Bioorganic & Medicinal Chemistry Letters | 2011
Li Xing; Bruce C. Hamper; Theresa R. Fletcher; Jay M. Wendling; Jeffery S Carter; James K. Gierse; Subo Liao
Combination of the structure-based design and solid-phase parallel synthesis provided an integrated approach to rapidly develop the structure-activity relationship of benzopyran COX-2 inhibitors. Binding free energies predicted by free energy perturbation theory yielded good agreement with experimental results. New potent and selective lead compounds with improved metabolic properties were identified.
Journal of Medicinal Chemistry | 2005
Horng-Chih Huang; Samuel J. Tremont; Len F. Lee; Bradley T. Keller; Andrew J. Carpenter; Ching-Cheng Wang; Shyamal C. Banerjee; Scott R. Both; Theresa R. Fletcher; Danny J. Garland; Wei Huang; Claude Jones; Kevin J. Koeller; Steve A. Kolodziej; James C. B. Li; Robert E. Manning; Matthew W. Mahoney; Raymond E. Miller; Deborah A. Mischke; Nigam P. Rath; Emily J. Reinhard; Michael B. Tollefson; William F. Vernier; Grace M. Wagner; Steve R. Rapp; Judy Beaudry; Kevin C. Glenn; Karen Regina; Joe R. Schuh; Mark E. Smith
Bioorganic & Medicinal Chemistry Letters | 2010
Mark E. Schnute; Patrick Michael O'brien; Joe Nahra; Mark Morris; W. Howard Roark; Cathleen E. Hanau; Peter G. Ruminski; Jeffrey A. Scholten; Theresa R. Fletcher; Bruce C. Hamper; Jeffery N. Carroll; William Chester Patt; Huey Shieh; Brandon Collins; Alexander Pavlovsky; Katherine E. Palmquist; Karl W. Aston; Jeffrey Hitchcock; Michael D. Rogers; Joseph J. Mcdonald; Adam R. Johnson; Grace E. Munie; Arthur J. Wittwer; Chiu-Fai Man; Steven L. Settle; Olga V. Nemirovskiy; Lillian E. Vickery; Arun Agawal; Richard D. Dyer; Teresa Sunyer
Bioorganic & Medicinal Chemistry Letters | 2003
Michael B. Tollefson; Stephen A. Kolodziej; Theresa R. Fletcher; William F. Vernier; Judith A. Beaudry; Bradley T. Keller; David B. Reitz
Archive | 2004
He Huang; Michael A. Stealey; Gunnar J. Hanson; Patrick J. Lennon; Bruce C. Hamper; Jin Xie; David S. Oburn; Serge G. Wolfson; Theresa R. Fletcher; Richard F. Heier; Matthew T. Reding; Michael Clare
Archive | 2005
Dominique Bonafoux; Michael Clare; Theresa R. Fletcher; Bruce C. Hamper; Patrick J. Lennon; William D. Mcghee; David S. Oburn; Matthew T. Reding; Michael B. Tollefson; Serge G. Wolfson
Archive | 2004
Jeffery S Carter; David L. Brown; Li Xing; Karl Aston; John Robert Springer; Francis J. Koszyk; Steven W. Kramer; Sofya Tsymbalov; Renee M. Huff; Yi Yu; Bruce C. Hamper; Subo Laio; Angela Michelle Deprow; Theresa R. Fletcher; E Hallinan; James R. Kiefer; David Limburg; Lijuan Wang
Archive | 2010
Mark E. Schnute; Jeffery N. Carroll; Cathleen E. Hanau; Matthew David Mcreynolds; Jeffrey A. Scholten; Joseph J. Mcdonald; Margaret L. Grapperhaus; Mark A. Massa; Peter G. Ruminski; Michelle A. Schmidt; Joseph Walter Strohbach; Bruce C. Hamper; Theresa R. Fletcher; Michael David Rogers; Patrick Michael O'brien; Joe Nahra; Mark Anthony Morris; William Howard Roark